Literature DB >> 2069715

Nicotine-derived N-nitrosamines (TSNA) and their relevance in tobacco carcinogenesis.

D Hoffmann1, A Rivenson, F L Chung, S S Hecht.   

Abstract

Biochemical studies and bioassays support the concept that the increased risk for cancer of the oral cavity in snuff dippers and cancer of the lung, upper aerodigestive tract, and pancreas in smokers is most likely associated with the exposure to tobacco-specific N-nitrosamines. The doses of TSNA required to induce tumors in the oral cavity in rats and tumors in the lungs of rats and hamsters are comparable to the total doses of TSNA to which a long-term snuff dipper, respectively a cigarette smoker, are exposed over 4 decades. The carcinogenic NNN and NNK are metabolized to highly reactive electrophiles which react with nucleophilic centers of DNA and with proteins. The DNA-adducts are known to cause miscoding which can activate K-ras proto-oncogenes. K-ras oncogenes have been detected in adenocarcinomas of the lung of smokers. TSNA also form globin adducts in the blood of laboratory animals as well as of snuff dippers and smokers. Such adducts are currently being evaluated for their significance as biochemical markers of exposure to TSNA. These biomarkers may also serve as indicators for the possible endogenous formation of TSNA in tobacco chewers and smokers. Additional research needs in TSNA carcinogenesis include the development of modified methods for the reduction of TSNA in tobacco and smoke, inhibition of TSNA carcinogenesis by nutrients and micro-nutrients and the testing of chemopreventive agents.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2069715     DOI: 10.3109/10408449109017917

Source DB:  PubMed          Journal:  Crit Rev Toxicol        ISSN: 1040-8444            Impact factor:   5.635


  15 in total

1.  Role of nitric oxide in the induction of apoptosis by smokeless tobacco extract.

Authors:  R S Mangipudy; J K Vishwanatha
Journal:  Mol Cell Biochem       Date:  1999-10       Impact factor: 3.396

Review 2.  Treatment of pancreatic cancer. Promises and problems of tamoxifen, somatostatin analogs, and gemcitabine.

Authors:  L Rosenberg
Journal:  Int J Pancreatol       Date:  1997-10

Review 3.  The pathobiological impact of cigarette smoke on pancreatic cancer development (review).

Authors:  Uwe A Wittel; Navneet Momi; Gabriel Seifert; Thorsten Wiech; Ulrich T Hopt; Surinder K Batra
Journal:  Int J Oncol       Date:  2012-03-23       Impact factor: 5.650

4.  Beta-adrenergic signaling in the development and progression of pulmonary and pancreatic adenocarcinoma.

Authors:  Hildegard M Schuller; Hussein A N Al-Wadei
Journal:  Curr Cancer Ther Rev       Date:  2012-05-01

Review 5.  Pancreatic cancer: a review of emerging therapies.

Authors:  L Rosenberg
Journal:  Drugs       Date:  2000-05       Impact factor: 9.546

Review 6.  β-Adrenergic modulation of cancer cell proliferation: available evidence and clinical perspectives.

Authors:  Marisa Coelho; Cátia Soares-Silva; Daniela Brandão; Franca Marino; Marco Cosentino; Laura Ribeiro
Journal:  J Cancer Res Clin Oncol       Date:  2016-10-05       Impact factor: 4.553

7.  Determination of tobacco specific hemoglobin adducts in smoking mothers and new born babies by mass spectrometry.

Authors:  Steven R Myers; Md Yeakub Ali
Journal:  Biomark Insights       Date:  2007-08-06

8.  Modulation of annexin I and cyclooxygenase-2 in smokeless tobacco-induced inflammation and oral cancer.

Authors:  Jamboor K Vishwanatha; Ryan Swinney; Abhijit G Banerjee
Journal:  Mol Cell Biochem       Date:  2003-06       Impact factor: 3.396

9.  Chemical and toxicological characteristics of conventional and low-TSNA moist snuff tobacco products.

Authors:  Min-Ae Song; Catalin Marian; Theodore M Brasky; Sarah Reisinger; Mirjana Djordjevic; Peter G Shields
Journal:  Toxicol Lett       Date:  2016-01-21       Impact factor: 4.372

10.  The role of tobacco-derived carcinogens in pancreas cancer.

Authors:  Rajiv Lochan; Helen L Reeves; Anne K Daly; Richard M Charnley
Journal:  ISRN Oncol       Date:  2011-07-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.